The latest closing stock price for Zentalis Pharmaceuticals as of February 21, 2025 is 2.32.
An investor who bought $1,000 worth of Zentalis Pharmaceuticals stock at the IPO in 2020 would have $-900 today, roughly -1 times their original investment - a -36.90% compound annual growth rate over 5 years.
The all-time high Zentalis Pharmaceuticals stock closing price was 84.79 on November 03, 2021.
The Zentalis Pharmaceuticals 52-week high stock price is 18.07, which is 678.9% above the current share price.
The Zentalis Pharmaceuticals 52-week low stock price is 1.61, which is 30.6% below the current share price.
The average Zentalis Pharmaceuticals stock price for the last 52 weeks is 6.32.
An investor who bought $1,000 worth of Zentalis Pharmaceuticals stock at the IPO in 2020 would have $-900 today, roughly -1 times their original investment - a -36.90% compound annual growth rate over 5 years.
The all-time high Zentalis Pharmaceuticals stock closing price was 84.79 on November 03, 2021.
The Zentalis Pharmaceuticals 52-week high stock price is 18.07, which is 678.9% above the current share price.
The Zentalis Pharmaceuticals 52-week low stock price is 1.61, which is 30.6% below the current share price.
The average Zentalis Pharmaceuticals stock price for the last 52 weeks is 6.32.